MBX Biosciences（MBX.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

股东类型

机构投资者69.82%
风投/私募23.45%
对冲基金4.41%
个人与内部人士2.32%

主要股东

主要股东最新
股东
Frazier Life Sciences Management, LP	13.81%	665.20 万	0.06%	+0	2026/08/06
FMR LLC	11.05%	532.28 万	4.88%	+238.62 万	2026/06/30
Wellington Management Group LLP	10.34%	497.75 万	3.63%	+178.57 万	2026/06/30
New Enterprise Associates, Inc.	7.51%	361.45 万	0.09%	+0	2026/06/30
BlackRock, Inc.	6.90%	332.37 万	0.72%	+38.23 万	2026/06/30
OrbiMed Advisors LLC	6.38%	307.49 万	0.77%	-35.39 万	2026/08/10
Paradigm Biocapital Advisors LP	5.21%	250.80 万	--	+250.80 万	2026/06/30
NVP Associates, LLC	4.44%	213.63 万	0.05%	+0	2026/06/30
Deep Track Capital, LP	3.60%	173.26 万	2.20%	-102.50 万	2026/06/30
Vanguard Capital Management, LLC	3.49%	167.88 万	0.02%	+3.11 万	2026/06/30
Polar Capital Holdings Plc	3.34%	160.85 万	0.07%	-1.37 万	2026/06/30
Peter HawrylukFormer Executive Officer	2.52%	121.44 万	0.04%	+3.46 万	2026/05/06
Aaron Wealth Advisors LLC	2.42%	116.78 万	0.03%	-377.00	2026/06/30
Driehaus Capital Management LLC	2.19%	105.66 万	0.05%	+3.84 万	2026/06/30
Kynam Capital Management, LP	1.94%	93.48 万	0.02%	+0	2026/06/30
Woodline Partners LP	1.87%	90.01 万	0.02%	+29.00	2026/06/30
Eventide Asset Management, LLC	1.81%	87.35 万	0.06%	-1.65 万	2026/06/30
State Street Investment Management	1.79%	86.45 万	0.14%	+7.73 万	2026/06/30
T. Rowe Price Group, Inc.	1.69%	81.48 万	0.47%	-21.42 万	2026/06/30
Parkman Healthcare Partners LLC	1.66%	80.02 万	0.02%	+136.00	2026/06/30